References
- Koprowski H, Steplewski Z, Mitchell K, Heriyn M, Fuhner P. Colo-rectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 1979; 5: 957–972
- Del Villano B C, Brennan S, Brock P, et al. Radio-immunometric assay for an antibody-defined tumor marker, CA19–9. Clin Chem 1983; 29: 549–552
- Lindholm L, Holmgren J, Svennerholm L, et al. Monoclonal antibodies against gastrointestinal tumor-associated antigens isolated as monosialogan-gliosides. Int Arch Allergy Appl Immunol 1983; 71: 178–181
- Holmgren J, Lindholm L, Persson B, et al. Detection by monoclonal antibody of carbohydrate antigen CA-50 in serum of patients with carcinoma. Br Med J 1984; 288: 1479–1482
- Metzgar R A, Gaillard M T, Levine S T, Tuck F L, Bossen E H, Borowitz M J. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res 1982; 2: 601–608
- Metzgar R A, Rodriguez N, Finn O J, Sandler R S, Seigler H F. Detection of a pancreatic cancer associated antigen (Du-Pan 2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 1984; 81: 5242–5246
- Fukushi Y, Nudelman E, Levery S B, Hakomori S, Rauvala H. Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglio-side (VI3NeuAcV3III3Fuc2-nLc6). J Biol Chem 1984; 259: 10511–10517
- Kannagi R, Fukushi Y, Tachikawa T, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialylfucosyl type 2 chain poly-actosamine. Cancer Res 1986; 46: 2619–2626
- Klug T L, LeDonne N C, Greber T F, Zurawski V R, Jr. Purification and composition of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lact-N-fucopentaose II(CA19–9). Cancer Res 1988; 48: 1505–1511
- Haga Y, Horiuchi S, Morino Y, Akagi M. Partial purification and characterization of CA19–9 antigen from the ascitic fluid of a patient with pancreatic cancer. Clin Biochem 1989; 22: 363–368
- Singhal A K, Orntoft T F, Nudelman E, et al. Profiles of Lewis”-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res 1990; 50: 1375–1380
- Kawa S, Kato M, Oguchi H, Kobayashi T, Furuta S, Kanai M. Preparation of pancreatic cancer-associated mucin expressing CA19–9, CA50, Span-1, Sialyl SSEA-1 and Dupan-2. Scand J Gastroenterol 1991; 26: 981–992
- Kobayashi T, Kawa S, Tokoo M, et al. Comparative study of CA50 (time-resolved fluoroimmunoassay), Span-1 and CA19–9 in the diagnosis of pancreatic cancer. Scand J Gastroenterol 1991; 26: 787–797
- Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4354
- Kannagi R, Hakomori S, Imura H. Cancer-associated serum glycoprotein antigens expressing type 1 and type 2 chain polylactosamines. Altered glycosilation in tumor cells, C L Reading, S Hakomori, D M Marcus. A.R.Liss, NewYork 1988; 279–294
- Fukui S, Horie T, Numata Y, et al. Characterization of mucin antigens recognized by monoclonal antibodies raised against human colon cancer cells. Cancer Res 1991; 51: 331–335
- Nardelli J, Byrd J C, Ho J, Fearney F J, Tasman-Jones C, Kim Y S. Pancreatic cancer mucin from xenografts of SW1990 cells: Isolation, characterization, and comparison to colon cancer mucin. Pancreas 1988; 3: 631–641